Therapy Response Assessments from RECIST and PERCIST
| Chemotherapy | ||
| Criteria | Before | After 2 courses |
| RECIST | ||
| Longest diameter (mm) | 59.9 ± 18.9 | 39.1 ± 19.5 |
| Reduction rate of tumor diameter (%) | 34.8 ± 21.8 | |
| Objective therapeutic response | ||
| CR/PR/stable disease/PD/not classifiable | 0/26/20/0/5 | |
| PERCIST | ||
| Tumor SULpeak | 7.15 ± 3.16 | 3.11 ± 1.92 |
| Liver SUL + 2 × (SD) | 2.06 ± 0.23 | 2.17 ± 0.31 |
| Reduction rate of tumor SULpeak (%) | 53.3 ± 23.4 | |
| Objective therapeutic response | ||
| CMR/PMR/SMD/PMD/not classifiable | 17/26/8/0/0 | 17/26/8/0/0 |
Not classifiable = uncategorizable using either RECIST or PERCIST.
Data are mean ± SD or n.